Comparable stake leader
JANUS HENDERSON GROUP PLC
SEC ownership of Vaxcyte, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001649094.
Disclosed value leader
JANUS HENDERSON GROUP PLC
Comparable rows
50/50
Latest evidence
26 Jun 2026
- Public ticker
- PCVX on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
JANUS HENDERSON GROUP PLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
JANUS HENDERSON GROUP PLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
26 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001649094
- Issuer location
- San Carlos, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Vaxcyte, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JANUS HENDERSON GROUP PLC
Disclosed value leader
JANUS HENDERSON GROUP PLC
Comparable rows
50/50
Latest evidence
26 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 12%
13D/G row: JANUS HENDERSON GROUP PLC
Showing 1-8 of 50 holder rows.
Quick read
JANUS HENDERSON GROUP PLC leads the comparable SEC ownership view at 12%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JANUS HENDERSON GROUP PLC's linked filing trail.
Comparable ownership
Top 5
JANUS HENDERSON GROUP PLC
12%
FMR LLC
11%
RA CAPITAL MANAGEMENT, L.P.
8.9%
T. Rowe Price Investment Manageme...
8.6%
BlackRock, Inc.
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
Company
|
12%
|
$1,023,560,281
16,575,875 shares
|
+$214,375,746 | 31 Mar 2026 |
| FMR LLC |
13D/G
13F
Company
|
11%
|
$1,015,853,037
16,451,061 shares
|
+$204,901,073 | 31 Mar 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
8.9%
|
$801,181,488
12,974,599 shares
|
+$624,169 | 31 Mar 2026 |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
Company
|
8.6%
from 13D/G
|
$704,643,000
12,126,017 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.6%
from 13D/G
|
$637,572,225
10,971,816 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5%
|
$421,416,800
7,252,053 shares
|
$0 | 31 Mar 2026 |
| Grant Pickering |
3/4/5
CHIEF EXECUTIVE OFFICER, Director
|
0.4%
|
$32,944,585
586,681 shares
|
-$2,622,475 | 26 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
4.3%
|
$364,904,360
6,279,545 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$5,402,167.
Buys
$0
Insiders: 0
Sells
$5,402,167
Insiders: 5
Net
-$5,402,167
Shares: -101,601
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 101,601
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 66,198 | $0 | $3,571,760 | -$3,571,760 |
| 3-6 | 0 | 14,037 | $0 | $818,544 | -$818,544 |
| 6-9 | 0 | 21,366 | $0 | $1,011,863 | -$1,011,863 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 23 reporting-owner rows connected to Vaxcyte, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
23
Largest Forms 3/4/5 holder
Grant Pickering
Net 12M change
-$5,402,168
Latest report
26 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Grant Pickering | CHIEF EXECUTIVE OFFICER, Director | $32,944,585 | -$2,622,475 | -7.4% | Filing P/S | 26 Jun 2026 |
| Jeff Fairman | VP, Research | $22,935,618 | Mixed | 30 Dec 2022 | ||
| Andrew Guggenhime | President And Cfo | $9,127,038 | -$530,000 | -5.5% | Mixed | 18 Jun 2026 |
| Jim Wassil | Chief Operating Officer | $7,965,432 | -$806,201 | -9.2% | Filing P/S | 01 Jun 2026 |
| Harpreet S. Dhaliwal | Chief Technical Ops Officer | $4,266,052 | -$454,891 | -9.6% | Mixed | 09 Mar 2026 |
| Mikhail Eydelman | Svp, Gen Counsel & Corp Sec | $3,012,039 | Filing P/S | 05 Mar 2025 | ||
| Elvia Cowan | SVP, Finance & CAO | $1,738,500 | -$988,601 | -36% | Filing P/S | 07 Apr 2026 |
| Halley E. Gilbert | Director | $1,171,058 | Mixed | 15 Jun 2026 | ||
| Heath Lukatch | Director | $1,132,040 | Median | 15 Jun 2026 | ||
| Peter Hirth | Director | $1,043,024 | Mixed | 06 Jun 2024 | ||
| Anne S. Drapeau | Director | $725,270 | Median | 15 Jun 2026 | ||
| Teri Loxam | Director | $725,270 | Median | 15 Jun 2026 | ||
| Carlos Paya V | Director | $725,270 | Median | 15 Jun 2026 | ||
| Jacks Lee | Director | $398,402 | Median | 15 Jun 2026 | ||
| Michael E. Kamarck | Director | $364,388 | Mixed | 13 Jun 2023 | ||
| John Furey | Director | $308,331 | Median | 15 Jun 2026 | ||
| Olivier Brandicourt | Director | $273,058 | Median | 15 Jun 2026 | ||
| Jane Wright-Mitchell | General Counsel | $202,438 | Mixed | 16 Aug 2021 | ||
| Moncef Slaoui | Director | Mixed | 22 Jun 2026 | |||
| Robert Lorne Hopfner | Director | Mixed | 02 Jun 2021 |
Recent insider transactions for Vaxcyte, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Grant Pickering | PCVX | Common Stock | Sale | -1.47% | $110,465 | $55.23 | -2,000 | 134,215 | 26 Jun 2026 | By Children's Trust |
| Grant Pickering | PCVX | Common Stock | Sale | -4.68% | $1,227,805 | $55.21 | -22,237 | 452,466 | 26 Jun 2026 | Direct |
| Moncef Slaoui | PCVX | Stock Option (right to buy) | Award | 26,061 | 26,061 | 22 Jun 2026 | Direct | |||
| Grant Pickering | PCVX | Common Stock | Sale | -1.46% | $105,000 | $52.50 | -2,000 | 135,215 | 18 Jun 2026 | By Children's Trust |
| Grant Pickering | PCVX | Common Stock | Sale | -4.52% | $1,179,205 | $52.50 | -22,461 | 474,703 | 18 Jun 2026 | Direct |
| Grant Pickering | PCVX | Common Stock | Options Exercise | 0.05% | 225 | 497,164 | 18 Jun 2026 | Direct | ||
| Grant Pickering | PCVX | Stock Option (right to buy) | Options Exercise | -100% | -225 | 0 | 18 Jun 2026 | Direct | ||
| Andrew Guggenhime | PCVX | Common Stock | Sale | -8.74% | $530,000 | $53.00 | -10,000 | 104,395 | 18 Jun 2026 | Direct |
| Andrew Guggenhime | PCVX | Common Stock | Options Exercise | 9.58% | 10,000 | 114,395 | 18 Jun 2026 | Direct | ||
| Andrew Guggenhime | PCVX | Stock Option (right to buy) | Options Exercise | -4.05% | -10,000 | 236,827 | 18 Jun 2026 | Direct | ||
| Carlos Paya V | PCVX | Common Stock | Award | 49.3% | 2,265 | 6,856 | 15 Jun 2026 | Direct | ||
| Carlos Paya V | PCVX | Stock Option (right to buy) | Award | 11,389 | 11,389 | 15 Jun 2026 | Direct | |||
| Olivier Brandicourt | PCVX | Common Stock | Award | 87.6% | 2,194 | 4,699 | 15 Jun 2026 | Direct | ||
| Olivier Brandicourt | PCVX | Stock Option (right to buy) | Award | 11,034 | 11,034 | 15 Jun 2026 | Direct | |||
| John Furey | PCVX | Common Stock | Award | 74.5% | 2,265 | 5,306 | 15 Jun 2026 | Direct | ||
| John Furey | PCVX | Stock Option (right to buy) | Award | 11,389 | 11,389 | 15 Jun 2026 | Direct | |||
| Jacks Lee | PCVX | Common Stock | Award | 49.3% | 2,265 | 6,856 | 15 Jun 2026 | Direct | ||
| Jacks Lee | PCVX | Stock Option (right to buy) | Award | 11,389 | 11,389 | 15 Jun 2026 | Direct | |||
| Halley E. Gilbert | PCVX | Common Stock | Award | 22.2% | 2,265 | 12,481 | 15 Jun 2026 | Direct | ||
| Halley E. Gilbert | PCVX | Stock Option (right to buy) | Award | 11,389 | 11,389 | 15 Jun 2026 | Direct | |||
| Teri Loxam | PCVX | Common Stock | Award | 22.2% | 2,265 | 12,481 | 15 Jun 2026 | Direct | ||
| Teri Loxam | PCVX | Stock Option (right to buy) | Award | 11,389 | 11,389 | 15 Jun 2026 | Direct | |||
| Anne S. Drapeau | PCVX | Common Stock | Award | 22.2% | 2,265 | 12,481 | 15 Jun 2026 | Direct | ||
| Anne S. Drapeau | PCVX | Stock Option (right to buy) | Award | 11,389 | 11,389 | 15 Jun 2026 | Direct | |||
| Heath Lukatch | PCVX | Common Stock | Award | 13.2% | 2,265 | 19,481 | 15 Jun 2026 | Direct | ||
| Heath Lukatch | PCVX | Stock Option (right to buy) | Award | 11,389 | 11,389 | 15 Jun 2026 | Direct | |||
| Jim Wassil | PCVX | Common Stock | Sale | -1.4% | $111,416 | $49.52 | -2,250 | 158,494 | 01 Jun 2026 | Direct |
| Jim Wassil | PCVX | Common Stock | Sale | -1.38% | $127,870 | $56.83 | -2,250 | 160,744 | 01 May 2026 | Direct |
| Elvia Cowan | PCVX | Common Stock | Sale | -9.38% | $180,000 | $60.00 | -3,000 | 28,975 | 07 Apr 2026 | Direct |
| Elvia Cowan | PCVX | Common Stock | Options Exercise | 10.4% | 3,000 | 31,975 | 07 Apr 2026 | Direct | ||
| Elvia Cowan | PCVX | Stock Option (right to buy) | Options Exercise | -3.12% | -3,000 | 93,068 | 07 Apr 2026 | Direct | ||
| Jim Wassil | PCVX | Common Stock | Sale | -1.36% | $131,476 | $58.43 | -2,250 | 162,994 | 01 Apr 2026 | Direct |
| Elvia Cowan | PCVX | Common Stock | Sale | -6.13% | $105,147 | $55.57 | -1,892 | 28,975 | 17 Mar 2026 | Direct |
| Elvia Cowan | PCVX | Common Stock | Sale | -7.49% | $146,482 | $58.59 | -2,500 | 30,867 | 11 Mar 2026 | Direct |
| Elvia Cowan | PCVX | Common Stock | Options Exercise | 8.1% | 2,500 | 33,367 | 11 Mar 2026 | Direct | ||
| Elvia Cowan | PCVX | Stock Option (right to buy) | Options Exercise | -2.54% | -2,500 | 96,068 | 11 Mar 2026 | Direct | ||
| Jim Wassil | PCVX | Common Stock | Sale | -4.24% | $435,440 | $58.88 | -7,395 | 166,818 | 10 Mar 2026 | Direct |
| Grant Pickering | PCVX | Common Stock | Tax liability | -0.74% | -3,685 | 496,939 | 09 Mar 2026 | Direct | ||
| Andrew Guggenhime | PCVX | Common Stock | Tax liability | -0.97% | -1,021 | 104,395 | 09 Mar 2026 | Direct | ||
| Elvia Cowan | PCVX | Common Stock | Tax liability | -1.58% | -495 | 30,867 | 09 Mar 2026 | Direct | ||
| Jim Wassil | PCVX | Common Stock | Tax liability | -0.56% | -975 | 174,213 | 09 Mar 2026 | Direct | ||
| Harpreet S. Dhaliwal | PCVX | Common Stock | Tax liability | -0.79% | -604 | 75,976 | 09 Mar 2026 | Direct | ||
| Elvia Cowan | PCVX | Common Stock | Tax liability | -1.03% | -326 | 31,362 | 02 Mar 2026 | Direct | ||
| Andrew Guggenhime | PCVX | Common Stock | Tax liability | -0.95% | -1,009 | 105,416 | 02 Mar 2026 | Direct | ||
| Grant Pickering | PCVX | Common Stock | Tax liability | -0.5% | -2,531 | 500,624 | 02 Mar 2026 | Direct | ||
| Harpreet S. Dhaliwal | PCVX | Common Stock | Tax liability | -0.6% | -465 | 76,580 | 02 Mar 2026 | Direct | ||
| Jim Wassil | PCVX | Common Stock | Tax liability | -0.57% | -1,009 | 175,188 | 02 Mar 2026 | Direct | ||
| Elvia Cowan | PCVX | Common Stock | Tax liability | -0.76% | -243 | 31,688 | 28 Feb 2026 | Direct | ||
| Andrew Guggenhime | PCVX | Common Stock | Tax liability | -0.84% | -898 | 106,425 | 28 Feb 2026 | Direct | ||
| Grant Pickering | PCVX | Common Stock | Tax liability | -0.57% | -2,863 | 503,155 | 28 Feb 2026 | Direct |
* marks a reported price that did not pass the local price check.